Phase II, Single-arm Exploratory Clinical Study of Tislelizumab Combined With Anlotinib in the Treatment of Advanced Pulmonary Pleomorphic Carcinoma
Clinical trial NCT05375734 · COMPLETED
Trial details
- NCT number
- NCT05375734
- Sponsor
- Second Affiliated Hospital of Nanchang University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-17
- Primary completion
- 2025-07-25
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.